239 related articles for article (PubMed ID: 11731800)
1. T cells down-modulate peptide-MHC complexes on APCs in vivo.
Kedl RM; Schaefer BC; Kappler JW; Marrack P
Nat Immunol; 2002 Jan; 3(1):27-32. PubMed ID: 11731800
[TBL] [Abstract][Full Text] [Related]
2. Lack of fair play in the T cell response.
Lanzavecchia A
Nat Immunol; 2002 Jan; 3(1):9-10. PubMed ID: 11753400
[No Abstract] [Full Text] [Related]
3. Immunotherapy with dendritic cells and tumor major histocompatibility complex class I-derived peptides requires a high density of antigen on tumor cells.
Rawson P; Hermans IF; Huck SP; Roberts JM; Pircher H; Ronchese F
Cancer Res; 2000 Aug; 60(16):4493-8. PubMed ID: 10969797
[TBL] [Abstract][Full Text] [Related]
4. Capture of membrane components via trogocytosis occurs in vivo during both dendritic cells and target cells encounter by CD8(+) T cells.
Riond J; Elhmouzi J; Hudrisier D; Gairin JE
Scand J Immunol; 2007 Oct; 66(4):441-50. PubMed ID: 17850589
[TBL] [Abstract][Full Text] [Related]
5. Self peptide/MHC class I complexes have a negligible effect on the response of some CD8+ T cells to foreign antigen.
Spörri R; Reis e Sousa C
Eur J Immunol; 2002 Nov; 32(11):3161-70. PubMed ID: 12555661
[TBL] [Abstract][Full Text] [Related]
6. Reduced antigen concentration and costimulatory blockade increase IFN-gamma secretion in naive CD8+ T cells.
Hall HT; Petrovic J; Höglund P
Eur J Immunol; 2004 Nov; 34(11):3091-101. PubMed ID: 15384046
[TBL] [Abstract][Full Text] [Related]
7. Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes.
Coles RM; Jones CM; Brooks AG; Cameron PU; Heath WR; Carbone FR
Eur J Immunol; 2003 Jun; 33(6):1557-67. PubMed ID: 12778473
[TBL] [Abstract][Full Text] [Related]
8. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
[TBL] [Abstract][Full Text] [Related]
9. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro.
George TC; Bilsborough J; Viney JL; Norment AM
Eur J Immunol; 2003 Feb; 33(2):502-11. PubMed ID: 12645949
[TBL] [Abstract][Full Text] [Related]
10. Human Flt-3-ligand-mobilized dendritic cells require additional activation to drive effective immune responses.
Diener KR; Moldenhauer LM; Lyons AB; Brown MP; Hayball JD
Exp Hematol; 2008 Jan; 36(1):51-60. PubMed ID: 17949888
[TBL] [Abstract][Full Text] [Related]
11. RAG-dependent peripheral T cell receptor diversification in CD8+ T lymphocytes.
Serra P; Amrani A; Han B; Yamanouchi J; Thiessen SJ; Santamaria P
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15566-71. PubMed ID: 12432095
[TBL] [Abstract][Full Text] [Related]
12. Extended presentation of specific MHC-peptide complexes by mature dendritic cells compared to other types of antigen-presenting cells.
Zehn D; Cohen CJ; Reiter Y; Walden P
Eur J Immunol; 2004 Jun; 34(6):1551-60. PubMed ID: 15162424
[TBL] [Abstract][Full Text] [Related]
13. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
Robson NC; Donachie AM; Mowat AM
Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
[TBL] [Abstract][Full Text] [Related]
15. Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells.
Setterblad N; Blancheteau V; Delaguillaumie A; Michel F; Bécart S; Lombardi G; Acuto O; Charron D; Mooney N
J Leukoc Biol; 2004 Jun; 75(6):1036-44. PubMed ID: 14982950
[TBL] [Abstract][Full Text] [Related]
16. Rafting MHC-II domains in the APC (presynaptic) plasma membrane and the thresholds for T-cell activation and immunological synapse formation.
Gombos I; Detre C; Vámosi G; Matkó J
Immunol Lett; 2004 Mar; 92(1-2):117-24. PubMed ID: 15081535
[TBL] [Abstract][Full Text] [Related]
17. Recognition of an MHC class I-restricted antigenic peptide can be modulated by para-substitution of its buried tyrosine residues in a TCR-specific manner.
Saito NG; Chang HC; Paterson Y
J Immunol; 1999 May; 162(10):5998-6008. PubMed ID: 10229839
[TBL] [Abstract][Full Text] [Related]
18. Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo.
Ma H; Kapp JA
Cell Immunol; 2001 Nov; 214(1):89-96. PubMed ID: 11902833
[TBL] [Abstract][Full Text] [Related]
19. Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells.
Shastri N; Gonzalez F
J Immunol; 1993 Apr; 150(7):2724-36. PubMed ID: 8454852
[TBL] [Abstract][Full Text] [Related]
20. T cells acquire cell surface determinants of APC via in vivo trogocytosis during viral infections.
Rosenits K; Keppler SJ; Vucikuja S; Aichele P
Eur J Immunol; 2010 Dec; 40(12):3450-7. PubMed ID: 21080375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
